- Home
- OCEAW vs DAVEW Comparison
OCEAW vs DAVEW Comparison
Compare OCEAW & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEAW
- DAVEW
- Stock Information
- Founded
- OCEAW N/A
- DAVEW 2015
- Country
- OCEAW United States
- DAVEW United States
- Employees
- OCEAW 7
- DAVEW 285
- Industry
- OCEAW Biotechnology: Pharmaceutical Preparations
- DAVEW Retail: Computer Software & Peripheral Equipment
- Sector
- OCEAW Health Care
- DAVEW Technology
- Exchange
- OCEAW Nasdaq
- DAVEW Nasdaq
- Market Cap
- OCEAW N/A
- DAVEW N/A
- IPO Year
- OCEAW 2021
- DAVEW N/A
- Fundamental
- Price
- OCEAW $0.02
- DAVEW $0.18
- Analyst Decision
- OCEAW
- DAVEW
- Analyst Count
- OCEAW 0
- DAVEW 0
- Target Price
- OCEAW N/A
- DAVEW N/A
- AVG Volume (30 Days)
- OCEAW N/A
- DAVEW 46.1K
- Earning Date
- OCEAW N/A
- DAVEW 03-06-2025
- Dividend Yield
- OCEAW N/A
- DAVEW N/A
- EPS Growth
- OCEAW N/A
- DAVEW N/A
- EPS
- OCEAW N/A
- DAVEW 3.12
- Revenue
- OCEAW N/A
- DAVEW $319,355,000.00
- Revenue This Year
- OCEAW N/A
- DAVEW N/A
- Revenue Next Year
- OCEAW N/A
- DAVEW N/A
- P/E Ratio
- OCEAW N/A
- DAVEW $34.00
- Revenue Growth
- OCEAW N/A
- DAVEW 30.00
- 52 Week Low
- OCEAW N/A
- DAVEW $0.28
- 52 Week High
- OCEAW N/A
- DAVEW $0.32
- Technical
- Relative Strength Index (RSI)
- OCEAW N/A
- DAVEW N/A
- Support Level
- OCEAW N/A
- DAVEW N/A
- Resistance Level
- OCEAW N/A
- DAVEW N/A
- Average True Range (ATR)
- OCEAW 0.00
- DAVEW 0.00
- MACD
- OCEAW 0.00
- DAVEW 0.00
- Stochastic Oscillator
- OCEAW 0.00
- DAVEW 0.00
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
About DAVEW Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.